Pharma and Biotech
By Michele Maatouk
Date: Monday 16 Dec 2024
(Sharecast News) - Biotech firm Graft Polymer said on Monday that it has agreed to buy Awakn Life Sciences Corp, a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders, for £4.98m.
No recent information was found.
Currency | UK Pounds |
Share Price | 0.31p |
Change Today | 0.006p |
% Change | -1.74 % |
52 Week High | 0.36 |
52 Week Low | 0.12 |
Volume | 38,614,086 |
Shares Issued | 6,242m |
Market Cap | £19.63m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
10:49 | 45,227 @ 0.33p |
10:45 | 100,000 @ 0.32p |
10:30 | 4,000,000 @ 0.32p |
10:26 | 3,343 @ 0.31p |
10:17 | 467,880 @ 0.32p |
CEO | Anthony Tennyson |
Chair | Dennis Purcell |
Finance Director | Ryan Neats |
You are here: research